Bosh sahifa601607 ⢠SHA
add
Shanghai Pharmaceuticals Holding Ord Shs A
Yopilish kursi
17,17Ā Ā„
Kunlik diapazon
17,11Ā Ā„ - 17,20Ā Ā„
Yillik diapazon
16,94Ā Ā„ - 19,68Ā Ā„
Bozor kapitalizatsiyasi
57,09Ā mlrd CNY
Oʻrtacha hajm
8,61Ā mln
Narx/foyda
11,28
Dividend daromadliligi
2,39%
Asosiy maydon
SHA
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 73,48Ā mlrd | 4,65% |
Joriy xarajat | 5,58Ā mlrd | 14,38% |
Sof foyda | 688,20Ā mln | -38,13% |
Sof foyda marjasi | 0,94 | -40,51% |
Har bir ulushga tushum | ā | ā |
EBITDA | 2,26Ā mlrd | -13,12% |
Amaldagi soliq stavkasi | 32,89% | ā |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 44,55Ā mlrd | 5,10% |
Jami aktivlari | 236,75Ā mlrd | 5,81% |
Jami passivlari | 147,12Ā mlrd | 4,65% |
Umumiy kapital | 89,62Ā mlrd | ā |
Tarqatilgan aksiyalar | 3,71Ā mlrd | ā |
Narxi/balansdagi bahosi | 0,84 | ā |
Aktivlardan daromad | 1,98% | ā |
Kapitaldan daromad | 3,14% | ā |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 688,20Ā mln | -38,13% |
Operatsiyalardan naqd pul | 1,36Ā mlrd | -40,00% |
Sarmoyadan naqd pul | 449,96Ā mln | 126,86% |
Moliyadan naqd pul | -4,31Ā mlrd | -18,77% |
Naqd pulning sof oʻzgarishi | -2,49 mlrd | 18,18% |
Boʻsh pul | -3,15 mlrd | -7,21% |
Haqida
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Tashkil etilgan
18-yan, 1994
Sayt
Xodimlar soni
50Ā 120